Universe Pharmaceuticals INC
$3.32
▲
15.75%
2026-04-21 10:02:02
www.universe-pharmacy.com
NCM: UPC
Explore Universe Pharmaceuticals INC stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.9 M
Current Price
$3.32
52W High / Low
$11 / $2
Stock P/E
—
Book Value
$99.64
Dividend Yield
—
ROCE
-5.19%
ROE
-7.23%
Face Value
—
EPS
$-8.06
Exp Qtr EPS
—
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
216
Beta
1.48
Debt / Equity
16.49
Current Ratio
4.07
Quick Ratio
3.9
Forward P/E
—
Price / Sales
0.1
Enterprise Value
$-22.61 M
EV / EBITDA
9.43
EV / Revenue
-1.27
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Bausch Health Companies Inc. | $5.91 | 14.05 | $3.02 B | — | 9.85% | 4.36% | $11.97 / $6.06 | $-1.5 |
| 2. | Regencell Bioscience Holdings Limited | $29.09 | — | $13.89 B | — | -57.45% | -54.81% | $83.6 / $0.7 | $0.01 |
| 3. | Akanda Corp. | $3.42 | — | $1.89 M | — | -102.48% | -60.86% | $209.03 / $2.29 | $22.67 |
| 4. | Lantheus Holdings, Inc. | $83.97 | 23.41 | $5.47 B | — | 16.66% | 21.45% | $108.91 / $47.25 | $16.87 |
| 5. | IM Cannabis Corp. | $0.41 | — | $3.13 M | — | 510.44% | -516.26% | $9.7 / $1.75 | $-0.45 |
| 6. | Amneal Pharmaceuticals, Inc. | $13.26 | 58.7 | $4.23 B | — | 14.23% | -80.04% | $15.42 / $7.01 | $-0.23 |
| 7. | Amphastar Pharmaceuticals, Inc. | $22.92 | 10.43 | $1.02 B | — | 9.54% | 12.9% | $31.26 / $17.03 | $17.28 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 17.86 M | 23.02 M | 32.31 M | 40.14 M |
| Operating Profit | -2.92 M | -8.02 M | -3.97 M | -7.02 M |
| Net Profit | -3.67 M | -8.73 M | -6.58 M | -7.91 M |
| EPS in Rs | -6.52 | -15.49 | -11.68 | -14.04 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 69.3 M | 67.95 M | 41.72 M | 59.54 M |
| Total Liabilities | 13.17 M | 22.45 M | 13.75 M | 13.1 M |
| Equity | 56.13 M | 45.5 M | 27.97 M | 46.44 M |
| Current Assets | 53.6 M | 51.64 M | 25.27 M | 41.51 M |
| Current Liabilities | 13.17 M | 20.31 M | 13.75 M | 13.1 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -5.05 M | -9.51 M | 1.12 M | -1.3 M |
| Investing CF | -0.34 M | -0.36 M | -0.04 M | -3.91 M |
| Financing CF | 9.73 M | 33.95 M | -1.39 M | 3.32 M |
| Free CF | -5.4 M | -9.87 M | 1.07 M | -1.4 M |
| Capex | -0.35 M | -0.36 M | -0.04 M | -0.09 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -28.74% | -19.52% | — | — |
| Earnings Growth % | -32.61% | 16.8% | — | — |
| Profit Margin % | -37.9% | -20.37% | -19.7% | — |
| Operating Margin % | -34.83% | -12.28% | -17.49% | — |
| Gross Margin % | 26.37% | 31.93% | 54.53% | — |
| EBITDA Margin % | -31.95% | -11.33% | -15.94% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2025-03-24 | 1:0.025 |
| 2024-11-18 | 1:0.0666667 |
| 2023-07-28 | 1:0.166667 |